Genelux GmbH
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis (NCT01443260) | Genelux GmbH | 2012-02-01 |
| Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors (NCT00794131) | Genelux GmbH | 2008-11-01 |
Track Genelux GmbH automatically
Every clearance here is in the API, with alerts when new ones post.